Lung cancer patient saved through clinical trial for TILs therapy 

Margie Baylis was one of the first patients to ever receive TILs (tumor infiltrating lymphocytes) therapy for lung cancer, thanks to the clinical trials available through UofL Health - Brown Cancer Center. The Brown Cancer Center was among the first cancer centers in the U.S. to offer TILs and is now one of the most experienced, with clinical trials leading to the FDA approval of TILs for metastatic melanoma this past February. Trials are currently underway at Brown Cancer Center for other cancer types including lung, cervical, and head and neck cancers.
uoflhealth.org...
Learn more about UofL Health: uoflhealth.org/
Find a provider: uoflhealth.org...
Find a location: uoflhealth.org...
Find a specialty or service: uoflhealth.org...
Follow us on social: uoflhealth.org... | #PowerofU